Cryptosporidiosis and Enteropathogens in Bangladesh

Cryptosporidiosis

Cryptosporidium Species in Sohag Governorate A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea Field Studies of Amebiasis in Bangladesh Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium The Effectiveness of Cow’s Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children Open-Label “Compassionate” Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study Treatment of Cryptosporidiosis Cryptosporidiosis and Enteropathogens in Bangladesh Transmission and the Respiratory Tract in Cryptosporidiosis A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 Treatment of Chronic Cryptosporidiosis in AIDS Patients